Source: UK Business Angels Association

Presentient: QVentures invests in Presentient Technologies, a SaaS platform developing tools for clinical trials

Venture Capital firm, QVentures, announces their latest pre-seed fund investment into Presentient Technologies, a software platform developing innovative tools for companies running clinical trials. The funding round was led by QVentures with participation from Episode1 and industry angels. Clinical trials [...]The post QVentures invests in Presentient Technologies, a SaaS platform developing tools for clinical trials appeared first on UK Business Angels Association.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Tom Coates's photo - Co-Founder of Presentient

Co-Founder

Tom Coates

CEO Approval Rating

90/100

Read more